e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Quality of life and respiratory symptom management in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Possible cut-off values for stable or instable COPD as measured by the clinical COPD questionnaire (CCQ)
M. Prinsen, E. Van Heijst, S. Schokker, C. de Jong, R. Riemersma, J. Kocks, T. van der Molen (Groningen, Netherlands)
Source:
Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Session:
Quality of life and respiratory symptom management in primary care
Session type:
Thematic Poster Session
Number:
692
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Prinsen, E. Van Heijst, S. Schokker, C. de Jong, R. Riemersma, J. Kocks, T. van der Molen (Groningen, Netherlands). Possible cut-off values for stable or instable COPD as measured by the clinical COPD questionnaire (CCQ). Eur Respir J 2011; 38: Suppl. 55, 692
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV
1
predict treatment failure during hospitalisation due to COPD exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 525s
Year: 2007
Clinical COPD questionnaire (CCQ) score and mortality
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012
Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts)
Source: International Congress 2014 – COPD markers
Year: 2014
An acute bronchitis questionnaire (AECB-SS) discriminates between GOLD categories for COPD severity in patients screened for the MOSAIC study
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004
A clinical study on the consistency of a pre-screening questionnaire (11-Q) and the BODE index on subjects with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 62s
Year: 2005
The value of short physical performance battery (SPPB) as an alternative component of the BODE Index in predicting death in chronic obstructive pulmonary disease (COPD) in the ERICA cohort.
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
CCQ and ACQ scores in obstructive lung disease: one questionnaire for all?
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Changes in COPD symptom control questionnaire (CCQ) scores after seven days of treatment with prednisolone of acute exacerbations in hospitalised patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003
Validity and reliability of the symptom domain of the clinical COPD questionnaire (CCQ)
Source: Eur Respir J 2006; 28: Suppl. 50, 807s
Year: 2006
Sensitivity of the clinical COPD questionnaire to measure disease control in COPD patients referred for pulmonary rehabilitation
Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles
Year: 2008
Scales of assesment in COPD. Correlation with clinical and functional parameters
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Asthma control questionnaire score (ACQ-5) predicts future risk of exacerbations
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Comparison of CAT and mMRC in terms of assessing symptom status in stable COPD patients
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
Source: ERJ Open Res, 7 (1) 00828-2020; 10.1183/23120541.00828-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept